NovaBay Pharmaceuticals Inc
NBY0.760USD
+0.008+1.10%
終値 02/06, 16:00（ET）15分遅れの株価
4.57M時価総額
0.12直近12ヶ月PER
詳細情報 NovaBay Pharmaceuticals Inc 企業名
NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The Company manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
NovaBay Pharmaceuticals Incの企業情報
企業コードNBY
会社名NovaBay Pharmaceuticals Inc
上場日Oct 26, 2007
最高経営責任者「CEO」Kazley (Michael John)
従業員数14
証券種類Ordinary Share
決算期末Oct 26
本社所在地2000 Powell St Ste 1150
都市EMERYVILLE
証券取引所NASDAQ OMX – NASDAQ Basic Amex
国United States of America
郵便番号94608-1804
電話番号15108998800
ウェブサイトhttps://novabay.com/
企業コードNBY
上場日Oct 26, 2007
最高経営責任者「CEO」Kazley (Michael John)
NovaBay Pharmaceuticals Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
933.00
+841.00%
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
67.00
-513.00%
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Director
Director
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
-26.00%
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--
Mr. Michael Kazley
Mr. Michael Kazley
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
933.00
+841.00%
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
67.00
-513.00%
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Director
Director
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
-26.00%
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--
収益内訳
FY2025Q3
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
会社から関連データがまだ開示されていません。
地域別USD
会社名
収益
比率
United States
521.00K
0.00%
事業別
地域別
会社から関連データがまだ開示されていません。
株主
更新時刻: Thu, Feb 5
更新時刻: Thu, Feb 5
株主統計
種類
株主統計
株主統計
比率
R01 Fund LP
45.02%
Framework Ventures Management LLC
45.02%
Lazar (David Elliot)
5.06%
The Vanguard Group, Inc.
1.45%
Poplar Point Capital Management LLC
0.81%
他の
2.63%
株主統計
株主統計
比率
R01 Fund LP
45.02%
Framework Ventures Management LLC
45.02%
Lazar (David Elliot)
5.06%
The Vanguard Group, Inc.
1.45%
Poplar Point Capital Management LLC
0.81%
他の
2.63%
種類
株主統計
比率
Corporation
90.04%
Individual Investor
5.07%
Investment Advisor
1.83%
Hedge Fund
0.81%
Investment Advisor/Hedge Fund
0.06%
Research Firm
0.01%
他の
2.18%
機関投資家保有株
更新時刻: Thu, Jan 1
更新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
41
3.14M
2.49%
+1.61M
2025Q3
38
1.37M
22.81%
-82.54K
2025Q2
43
1.43M
24.52%
+210.59K
2025Q1
42
1.34M
22.96%
+376.59K
2024Q4
40
546.91K
11.19%
+390.20K
2024Q3
42
126.44K
2.60%
+79.02K
2024Q2
44
12.01K
0.89%
-33.08K
2024Q1
44
12.73K
1.48%
-22.10K
2023Q4
45
34.29K
18.48%
+25.73K
2023Q3
47
15.18K
15.11%
-444.00
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
84.49K
0.07%
+84.22K
+31191.85%
Sep 30, 2025
Poplar Point Capital Management LLC
1.02M
0.81%
--
--
Oct 15, 2025
Geode Capital Management, L.L.C.
51.72K
0.04%
+17.90K
+52.92%
Sep 30, 2025
詳細を見る
関連ETF
更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
配当落ち日
種類
比率
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Nov 14, 2022
Merger
35→1
Nov 14, 2022
Merger
35→1
日付
配当落ち日
種類
比率
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Nov 14, 2022
Merger
35→1
Nov 14, 2022
Merger
35→1
Nov 14, 2022
Merger
35→1
Nov 14, 2022
Merger
35→1
